Phase II study of S‐1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off

A phase II study of S‐1 plus leucovorin (LV) given in a 4‐week schedule (2 weeks’ administration followed by 2 weeks’ rest) for patients with untreated metastatic colorectal cancer (mCRC) showed that the combination was effective, but grade 3 toxicities (diarrhea, stomatitis and anorexia) occurred a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin, Xu, Ruihua, Xu, Jianming, Denda, Tadamichi, Ikejiri, Koji, Shen, Lin, Toh, Yasushi, Shimada, Ken, Kato, Takeshi, Sakai, Kenji, Yamamoto, Manabu, Mishima, Hideyuki, Wang, Jinwan, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623741/
https://www.ncbi.nlm.nih.gov/pubmed/28763145
http://dx.doi.org/10.1111/cas.13335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623741/
https://www.ncbi.nlm.nih.gov/pubmed/28763145
http://dx.doi.org/10.1111/cas.13335

Ejemplares similares